Category: Bio-Ophthalmology

Month: 08 Aug 2012

Issue: not yet available

First clinical study of new ultrasound cyclo-coagulation device shows safety and efficacy in refractory glaucoma patients

Results from a phase 1 pilot study investigating the use of high intensity focused ultrasound (“HIFU”) have shown both safety and efficacy in patients with refractory glaucoma. The clinical research, led by a team at the Hopital Edouard Herriot in Lyon, France and supported by the company EyeTech Care [www.eyetechcare.com], showed that patients benefited from a significant (P<0.01) reduction of almost 36% three months after the treatment. According to the authors of the study, "the specific advantage of HIFU is that the energy can be focused through non-optically transparent media without un-controlled energy absorption, thus potentially reducing the effects on the adjacent tissues".

Back to previous

Related News

Gearoid Tuohy

editor

by Dr. Gearóid Tuohy   Dear EURETINA Members,   A very warm welcome to the December 4th, 2017 edition of EURETINA’s web-based digital magazine, “EURETINA Brief”. EURETINA are delighted to continue our delivery of up-to-date summary briefs on a range of topics of interest to retinal clinicians, specialists and researchers across Europe. This resource is […]